Aid For Cancer Research is categorized under Research and Development Laboratories in Brighton, MA and active since 1952.
Aid For Cancer Research was established in 1952, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Linne Segill at the company’s single location by writing to 33 Wade St, Brighton, Massachusetts MA 02135 or by phoning (617) 782-0500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aid For Cancer Research |
| Contact Person: | Linne Segill |
| Address: | 33 Wade St, Brighton, Massachusetts 02135 |
| Phone Number: | (617) 782-0500 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1952 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 6211110 |
| Share This Business: |
Aid For Cancer Research was started in 1952 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Linne Segill for inquiries that concern Aid For Cancer Research by calling the company number (617) 782-0500, as your correspondence is most welcome. Additionally, the physical location of the single location of Aid For Cancer Research can be found at the coordinates 42.339111,-71.160297 as well as the street address 33 Wade St in Brighton, Massachusetts 02135.
For its online presence, you may visit Aid For Cancer Research’s website at and engage with its social media outlets through on Twitter and on Facebook.